BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Sean McCarthy will participate on a panel titled "Specialty Pharma Play: Are We Near the End?" at the Bio International Convention in Atlanta, GA
News | 05. 21. 2009
